查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1933386

全球细胞库市场：市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的考察、未来预测（2026-2034）

Stem Cell Banking Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 261 Pages | 商品交期: 请询问到货日

价格

细胞库市场成长驱动因子

2025年全球细胞库市场规模达48.1亿美元，预计2026年将达50.1亿美元。预计到2034年将成长至82.2亿美元，预测期内年复合成长率（CAGR）为6.38%。北美地区将引领市场，2025年市场占有率将达到35.16%，这主要得益于其先进的医疗保健基础设施、慢性病高发生率以及脐带血库和组织库的广泛应用。

细胞库是指收集、处理和保存干细胞，以备未来医疗应用。遗传性疾病、癌症和心血管疾病等慢性疾病的日益普遍，以及干细胞采集、处理和保存技术的进步，推动全球干细胞年产量的成长。 Cordlife、CBR Systems, Inc. 和 LifeCell International Pvt. Ltd. 等公司投资拓展干细胞的应用，包括个人化干细胞库解决方案，进一步推动市场成长。根据美国癌症协会2025年的资料，预计美国将新增约200万例癌症病例，凸显了再生医学和干细胞保存服务日益成长的需求。

市场动态

市场驱动因素

慢性疾病的成长趋势

由于镰状细胞贫血、糖尿病和癌症等慢性疾病，需要进行干细胞移植的患者群体不断扩大，这推动了对细胞库的需求。根据美国血液学会2025年的资料，美国有7万至10万人患有镰状细胞贫血症。脐带血库和成人捐赠者登记数量的增加也提高了配型率，尤其是在代表性不足的群体中，并促进了年度干细胞采集量的成长。

其他显着的驱动因素包括：人们对再生医学的认识不断提高，孕产妇保健意识的增强促进了脐带血和组织库的建立，以及对生物样本库基础设施和自动化储存解决方案的投资。公私合作和政府对干细胞研究的支持也进一步推动了市场扩张。

市场限制因子

细胞库成本高

细胞库需要先进的低温系统、无菌物流和符合GMP标准的实验室，这些都是资本密集的。根据《2025年脐带血库展望》，在美国，脐带血的采集和处理成本在1675美元至2820美元之间，这限制了其在中低收入地区的普及。新兴国家高昂的营运成本和严格的偿付政策进一步限制了市场成长。

市场机会

干细胞应用范围的扩大

干细胞的临床应用范围不断扩大，包括治疗心肌梗塞、脊髓损伤和肝硬化，这带来了巨大的商机。越来越多的使用胚胎干细胞、诱导多能干细胞和脐带血干细胞的临床试验推动对高品质保存服务的需求。到2025年，全球将有115项使用人类多能干细胞的临床试验进行中（Elsevier，2025）。基因编辑技术（例如 CRISPR-Cas9）的整合进一步拓展了潜在应用范围，推动了对个人化生物保险的需求。

市场挑战

监理与伦理考量

各国严格且不同的监管规定，例如美国的FDA 标准和 FACT 认证以及欧盟的组织和细胞指令，限制了市场渗透率。围绕胚胎干细胞的伦理问题也限制了研究和商业应用。根据 Springer Nature 发布的2025年报告，干细胞政策较为严格的国家（例如德国和法国）所进行中的临床试验数量少于监管较为宽鬆的国家。

市场趋势

对个人化生物保险的需求不断成长

人们对个人化医疗的认识不断提高，推动了透过私人生物保险库进行生物保险的需求。到2024年，全球私人血库将储存约 400万单位脐带血（Consumer Affairs 2024）。细胞库目前提供客製化的储存方案和多来源储存，涵盖脐带血、脐带组织和脂肪组织来源的干细胞，这反映了个人化医疗的发展趋势。

其他趋势包括区域性血库的整合与合併、冷冻保存技术的改进、线上註册模式以及医院、诊断实验室和生物样本库之间的合作。

市场区隔分析

依细胞类型

到2026年，脐带血/脐带组织来源的干细胞将占据市场主导地位，市场占有率达 59.98%，这主要得益于慢性病患病率的上升和个性化血库的扩展。预计脂肪组织来源的干细胞将以 6.6%的年复合成长率成长。

依服务类型

到2026年，标本保存和储存将以42.16%的市场占有率占据主导地位，这主要得益于临床试验和再生医学应用的成长。标本处理预计将以6.2%的年复合成长率成长。

依细胞库类型

到2026年，私人细胞库将以63.95%的市场占有率占据主导地位，这主要得益于脐带血采集数量的增加以及人们对个性化细胞库认知的提高。混合型细胞库预计将以6.9%的年复合成长率成长。

依应用

到2026年，个人化细胞库应用将占据最大的市场占有率，达到56.16%，这主要得益于对生物保险和干细胞疗法应用的需求不断成长。研究应用预计将以6.1%的年复合成长率成长。

区域展望

北美将持续维持领先地位，2025年市场规模将达到16.9亿美元，2026年将达到17.7亿美元，主要得益于美国每年新增3万株的产量成长。欧洲市场在2025年将达到15.4亿美元，而德国、英国和法国在2026年将分别纪录3.3亿美元、2.9亿美元和2.5亿美元的市场规模。到2025年，亚太地区的市场规模达到12.3亿美元，而印度和中国在2026年将分别达到2.9亿美元和3.6亿美元。拉丁美洲和中东及非洲在2025年的市场规模分别为1.9亿美元和8,000万美元。

目录

第1章 引言

第2章 执行摘要

第3章 市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场趋势

第4章 主要考察

  • 主要国家/地区主要疾病盛行率（2025/2026）
  • 主要国家/地区监理概览（2025/2026）
  • 主要产业趋势：併购、业务合作

第5章 全球细胞库市场分析：洞察与预测（2021-2034）

  • 市场分析、洞察与预测：依细胞类型划分
    • 週边血干细胞
    • 骨髓细胞
    • 脂肪组织来源干细胞
    • 脐带血/结缔组织来源干细胞
    • 其他
  • 市场分析、洞察与预测：依服务类型划分
    • 样本保存与储存
    • 样本分析
    • 样本处理
    • 采样和运输
  • 市场分析、洞察与预测：依细胞库类型划分
    • 公共细胞库
    • 私人细胞库
    • 混合型细胞库
  • 市场分析、洞察与预测：依应用划分
    • 研究应用
    • 临床应用
    • 个人化细胞库应用
  • 市场分析、洞察与预测：依地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第6章 北美细胞库市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 美国各州
    • 加拿大

第7章 欧洲细胞库市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 斯堪的纳维亚

第8章 亚太地区细胞库市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 日本
    • 澳洲
    • 中国
    • 印度
    • 东南亚
    • 亚太其他地区

第9章 拉丁美洲细胞库市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区

第10章 中东与非洲细胞库市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • GCC国家
    • 南非
    • 中东和非洲其他地区

第11章 竞争分析

  • 全球市场占有率分析（2026）
  • 公司简介
  • CBR Systems, Inc.
  • LifeCell International Pvt. Ltd.
  • Cordlife
  • Cryo-Cell International, Inc.
  • ViaCord
  • Cryoviva
  • Biocell
  • CryoSave South Africa（Pty）Ltd.
Product Code: FBI114449

Growth Factors of stem cell banking Market

The global stem cell banking market was valued at USD 4.81 billion in 2025 and is projected to reach USD 5.01 billion in 2026, eventually growing to USD 8.22 billion by 2034, exhibiting a CAGR of 6.38% during the forecast period. North America dominated the market in 2025 with a 35.16% share, attributed to the advanced healthcare infrastructure, high prevalence of chronic disorders, and widespread adoption of cord blood and tissue banking.

Stem cell banking involves collecting, processing, and storing stem cells for potential future medical applications. Rising prevalence of chronic conditions such as genetic disorders, cancer, and cardiovascular diseases, coupled with advancements in stem cell collection, processing, and storage technologies, has driven annual collections globally. Companies such as Cordlife, CBR Systems, Inc., and LifeCell International Pvt. Ltd. are investing in expanding stem cell applications, including personalized banking solutions, further supporting market growth. According to 2025 data from the American Cancer Society, around 2.0 million new cancer cases are projected in the U.S., highlighting the growing need for regenerative therapies and stem cell storage services.

Market Dynamics

Market Drivers

Rising Prevalence of Chronic Diseases

The growing patient pool for stem cell transplantation due to chronic disorders, such as sickle cell disease, diabetes, and cancer, is driving demand for stem cell banking. In the U.S., 70,000-100,000 individuals live with sickle cell disease, according to the American Society of Hematology 2025. Increased registries of cord blood units and adult donors also improve match rates, especially for underrepresented groups, boosting annual stem cell collections.

Other notable drivers include growing awareness of regenerative medicine, rising maternal healthcare awareness promoting cord blood/tissue banking, and investments in biobanking infrastructure and automated storage solutions. Public-private partnerships and governmental support for stem cell research further encourage market expansion.

Market Restraints

High Cost of Stem Cell Banking

Stem cell banking requires advanced cryogenic systems, sterile logistics, and GMP-compliant laboratories, which are capital-intensive. According to Cord Blood Banking 2025, collection and processing costs in the U.S. range between USD 1,675 and USD 2,820, limiting adoption in low- and middle-income regions. High operational expenditure and limited reimbursement policies in emerging nations further constrain market growth.

Market Opportunities

Expansion of Stem Cell Applications

Widening clinical applications, including treatments for myocardial infarction, spinal cord injuries, and liver cirrhosis, present lucrative opportunities. The increasing number of clinical trials involving embryonic, induced, and cord-blood-derived stem cells enhances demand for high-quality storage services. In 2025, 115 clinical trials involving human pluripotent stem cells were underway globally (Elsevier Inc., 2025). Integration of genetic editing technologies like CRISPR-CAS9 further expands potential applications, driving personalized banking demand.

Market Challenges

Regulatory and Ethical Considerations

Stringent and varied regulations across countries, such as FDA standards and FACT accreditation in the U.S., or the European Tissue and Cells Directive, limit market penetration. Ethical concerns surrounding embryonic stem cells also restrict research and commercial adoption. According to Springer Nature 2025, countries with stricter stem cell policies, including Germany and France, conducted fewer clinical trials compared to more permissive nations.

Market Trends

Increasing Demand for Personalized Banking

Growing awareness of personalized medicine has augmented demand for biological insurance through private banking. Approximately 4 million cord blood units were stored in private banks globally by 2024 (Consumer Affairs 2024). Stem cell banks now offer customized storage plans and multi-source preservation for cord blood, cord tissue, and adipose tissue-derived stem cells, reflecting the trend toward personalized healthcare.

Other trends include consolidation and mergers among regional banks, technological improvements in cryopreservation, online enrollment models, and collaborations between hospitals, diagnostic labs, and biobanks.

Segmentation Analysis

By Cell Type

The CB/CT-derived stem cells segment dominated in 2026 with 59.98% share, driven by the rising prevalence of chronic disorders and expansion of personalized banking. Adipose tissue-derived stem cells are projected to grow at a CAGR of 6.6%.

By Service Type

Sample preservation and storage led the market with 42.16% share in 2026, fueled by increasing clinical trials and regenerative therapy applications. Sample processing is expected to grow at a CAGR of 6.2%.

By Bank Type

The private segment dominated with a 63.95% share in 2026, due to higher cord blood collections and growing awareness of personalized banking. The hybrid segment is projected to grow at 6.9% CAGR.

By Application

Personalized banking applications held the dominant share in 2026 at 56.16%, supported by the growing demand for biological insurance and therapeutic use of stem cells. Research applications are projected to grow at 6.1% CAGR.

Regional Outlook

North America led with USD 1.69 billion in 2025 and USD 1.77 billion in 2026, primarily driven by U.S. collections totaling 30,000 new units annually. Europe reached USD 1.54 billion in 2025, with Germany, the U.K., and France recording USD 0.33 billion, USD 0.29 billion, and USD 0.25 billion in 2026, respectively. Asia Pacific was valued at USD 1.23 billion in 2025, with India and China reaching USD 0.29 billion and USD 0.36 billion in 2026. Latin America and Middle East & Africa were at USD 0.19 billion and USD 0.08 billion in 2025, respectively.

Competitive Landscape

Key players include CBR Systems, Inc., LifeCell International Pvt. Ltd., Cordlife, Cryo-Cell International, Inc., ViaCord, Cryoviva, Biocell, and CryoSave South Africa (Pty) Ltd. Strategic initiatives such as LifeCell's 2024 solution launch and Cryo-Cell's patent agreement with Duke University in 2023 highlight efforts to strengthen market presence globally.

Conclusion

The global stem cell banking market is projected to grow from USD 5.01 billion in 2026 to USD 8.22 billion by 2034, driven by increasing chronic disease prevalence, personalized medicine, technological advancements in storage and processing, and rising clinical trial activities. North America continues to dominate, while emerging regions such as Asia Pacific and Latin America present lucrative growth opportunities. Despite cost and regulatory challenges, the expansion of therapeutic applications and rising awareness of biological insurance are expected to sustain market growth through 2034.

Segmentation By Cell Type, Service Type, Bank Type, Application, and Region

By Cell Type * Peripheral Blood Stem Cells

  • Bone Marrow Cells
  • Adipose Tissue-Derived Stem Cells
  • CB/CT Derived Stem Cells
  • Others

By Service Type * Sample Preservation and Storage

  • Sample Analysis
  • Sample Processing
  • Sample Collection and Transportation

By Bank Type * Public

  • Private
  • Hybrid

By Application * Research Applications

  • Clinical Applications
  • Personalized Banking Applications

By Region * North America (By Cell Type, By Service Type, By Bank Type, By Application, and by Country)

    • U.S. (By Bank Type)
    • Canada (By Bank Type)
  • Europe (By Cell Type, By Service Type, By Bank Type, By Application, and by Country/Sub-region)
    • U.K. (By Bank Type)
    • Germany (By Bank Type)
    • France (By Bank Type)
    • Italy (By Bank Type)
    • Spain (By Bank Type)
    • Scandinavia (By Bank Type)
    • Rest of Europe (By Bank Type)
  • Asia Pacific (By Cell Type, By Service Type, By Bank Type, By Application, and by Country/Sub-region)
    • China (By Bank Type)
    • Japan (By Bank Type)
    • India (By Bank Type)
    • Australia (By Bank Type)
    • Southeast Asia (By Bank Type)
    • Rest of Asia Pacific (By Bank Type)
  • Latin America (By Cell Type, By Service Type, By Bank Type, By Application, and by Country/Sub-region)
    • Brazil (By Bank Type)
    • Mexico (By Bank Type)
    • Rest of Latin America (By Bank Type)
  • Middle East & Africa (By Cell Type, By Service Type, By Bank Type, By Application, and by Country/Sub-region)
    • GCC (By Bank Type)
    • South Africa (By Bank Type)
    • Rest of the Middle East & Africa (By Bank Type)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Key Disorders, Key Countries/Regions, 2025/2026
  • 4.2. Overview of Regulatory Scenario, Key Countries/Regions, 2025/2026
  • 4.3. Key Industry Developments - Mergers, Acquisitions & Partnerships

5. Global Stem Cell Banking Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Cell Type
    • 5.1.1. Peripheral Blood Stem Cells
    • 5.1.2. Bone Marrow Cells
    • 5.1.3. Adipose Tissue-Derived Stem Cells
    • 5.1.4. CB/CT Derived Stem Cells
    • 5.1.5. Others
  • 5.2. Market Analysis, Insights and Forecast - By Service Type
    • 5.2.1. Sample Preservation and Storage
    • 5.2.2. Sample Analysis
    • 5.2.3. Sample Processing
    • 5.2.4. Sample Collection and Transportation
  • 5.3. Market Analysis, Insights and Forecast - By Bank Type
    • 5.3.1. Public
    • 5.3.2. Private
    • 5.3.3. Hybrid
  • 5.4. Market Analysis, Insights and Forecast - By Application
    • 5.4.1. Research Applications
    • 5.4.2. Clinical Applications
    • 5.4.3. Personalized Banking Applications
  • 5.5. Market Analysis, Insights and Forecast - By Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Stem Cell Banking Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Cell Type
    • 6.1.1. Peripheral Blood Stem Cells
    • 6.1.2. Bone Marrow Cells
    • 6.1.3. Adipose Tissue-Derived Stem Cells
    • 6.1.4. CB/CT Derived Stem Cells
    • 6.1.5. Others
  • 6.2. Market Analysis, Insights and Forecast - By Service Type
    • 6.2.1. Sample Preservation and Storage
    • 6.2.2. Sample Analysis
    • 6.2.3. Sample Processing
    • 6.2.4. Sample Collection and Transportation
  • 6.3. Market Analysis, Insights and Forecast - By Bank Type
    • 6.3.1. Public
    • 6.3.2. Private
    • 6.3.3. Hybrid
  • 6.4. Market Analysis, Insights and Forecast - By Application
    • 6.4.1. Research Applications
    • 6.4.2. Clinical Applications
    • 6.4.3. Personalized Banking Applications
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
      • 6.5.1.1. By Bank Type
    • 6.5.2. Canada
      • 6.5.2.1. By Bank Type

7. Europe Stem Cell Banking Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Cell Type
    • 7.1.1. Peripheral Blood Stem Cells
    • 7.1.2. Bone Marrow Cells
    • 7.1.3. Adipose Tissue-Derived Stem Cells
    • 7.1.4. CB/CT Derived Stem Cells
    • 7.1.5. Others
  • 7.2. Market Analysis, Insights and Forecast - By Service Type
    • 7.2.1. Sample Preservation and Storage
    • 7.2.2. Sample Analysis
    • 7.2.3. Sample Processing
    • 7.2.4. Sample Collection and Transportation
  • 7.3. Market Analysis, Insights and Forecast - By Bank Type
    • 7.3.1. Public
    • 7.3.2. Private
    • 7.3.3. Hybrid
  • 7.4. Market Analysis, Insights and Forecast - By Application
    • 7.4.1. Research Applications
    • 7.4.2. Clinical Applications
    • 7.4.3. Personalized Banking Applications
  • 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.5.1. U.K.
      • 7.5.1.1. By Bank Type
    • 7.5.2. Germany
      • 7.5.2.1. By Bank Type
    • 7.5.3. France
      • 7.5.3.1. By Bank Type
    • 7.5.4. Spain
      • 7.5.4.1. By Bank Type
    • 7.5.5. Italy
      • 7.5.5.1. By Bank Type
    • 7.5.6. Scandinavia
  • 7.6. By Bank Type
    • 7.6.1. Rest of Europe
      • 7.6.1.1. By Bank Type

8. Asia Pacific Stem Cell Banking Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Cell Type
    • 8.1.1. Peripheral Blood Stem Cells
    • 8.1.2. Bone Marrow Cells
    • 8.1.3. Adipose Tissue-Derived Stem Cells
    • 8.1.4. CB/CT Derived Stem Cells
    • 8.1.5. Others
  • 8.2. Market Analysis, Insights and Forecast - By Service Type
    • 8.2.1. Sample Preservation and Storage
    • 8.2.2. Sample Analysis
    • 8.2.3. Sample Processing
    • 8.2.4. Sample Collection and Transportation
  • 8.3. Market Analysis, Insights and Forecast - By Bank Type
    • 8.3.1. Public
    • 8.3.2. Private
    • 8.3.3. Hybrid
  • 8.4. Market Analysis, Insights and Forecast - By Application
    • 8.4.1. Research Applications
    • 8.4.2. Clinical Applications
    • 8.4.3. Personalized Banking Applications
  • 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.5.1. Japan
      • 8.5.1.1. By Bank Type
    • 8.5.2. Australia
      • 8.5.2.1. By Bank Type
    • 8.5.3. China
      • 8.5.3.1. By Bank Type
    • 8.5.4. India
      • 8.5.4.1. By Bank Type
    • 8.5.5. Southeast Asia
      • 8.5.5.1. By Bank Type
    • 8.5.6. Rest of Asia Pacific
      • 8.5.6.1. By Bank Type

9. Latin America Stem Cell Banking Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Cell Type
    • 9.1.1. Peripheral Blood Stem Cells
    • 9.1.2. Bone Marrow Cells
    • 9.1.3. Adipose Tissue-Derived Stem Cells
    • 9.1.4. CB/CT Derived Stem Cells
    • 9.1.5. Others
  • 9.2. Market Analysis, Insights and Forecast - By Service Type
    • 9.2.1. Sample Preservation and Storage
    • 9.2.2. Sample Analysis
    • 9.2.3. Sample Processing
    • 9.2.4. Sample Collection and Transportation
  • 9.3. Market Analysis, Insights and Forecast - By Bank Type
    • 9.3.1. Public
    • 9.3.2. Private
    • 9.3.3. Hybrid
  • 9.4. Market Analysis, Insights and Forecast - By Application
    • 9.4.1. Research Applications
    • 9.4.2. Clinical Applications
    • 9.4.3. Personalized Banking Applications
  • 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.5.1. Brazil
      • 9.5.1.1. By Bank Type
    • 9.5.2. Mexico
      • 9.5.2.1. By Bank Type
    • 9.5.3. Rest of Latin America
      • 9.5.3.1. By Bank Type

10. Middle East & Africa Stem Cell Banking Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Cell Type
    • 10.1.1. Peripheral Blood Stem Cells
    • 10.1.2. Bone Marrow Cells
    • 10.1.3. Adipose Tissue-Derived Stem Cells
    • 10.1.4. CB/CT Derived Stem Cells
    • 10.1.5. Others
  • 10.2. Market Analysis, Insights and Forecast - By Service Type
    • 10.2.1. Sample Preservation and Storage
    • 10.2.2. Sample Analysis
    • 10.2.3. Sample Processing
    • 10.2.4. Sample Collection and Transportation
  • 10.3. Market Analysis, Insights and Forecast - By Bank Type
    • 10.3.1. Public
    • 10.3.2. Private
    • 10.3.3. Hybrid
  • 10.4. Market Analysis, Insights and Forecast - By Application
    • 10.4.1. Research Applications
    • 10.4.2. Clinical Applications
    • 10.4.3. Personalized Banking Applications
  • 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.5.1. GCC
      • 10.5.1.1. By Bank Type
    • 10.5.2. South Africa
      • 10.5.2.1. By Bank Type
    • 10.5.3. Rest of the Middle East & Africa
      • 10.5.3.1. By Bank Type

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2026)
  • 11.2. Company Profiles (Overview, Services, SWOT analysis, Recent developments, strategies, financials (based on availability))
    • 11.2.1. CBR Systems, Inc.
    • 11.2.2. LifeCell International Pvt. Ltd.
    • 11.2.3. Cordlife
    • 11.2.4. Cryo-Cell International, Inc.
    • 11.2.5. ViaCord
    • 11.2.6. Cryoviva
    • 11.2.7. Biocell
    • 11.2.8. CryoSave South Africa (Pty) Ltd.

List of Tables

  • Table 1: Global Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Cell Type, 2021-2034
  • Table 2: Global Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Service Type, 2021-2034
  • Table 3: Global Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 4: Global Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Application, 2021-2034
  • Table 5: Global Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Region, 2021-2034
  • Table 6: North America Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Cell Type, 2021-2034
  • Table 7: North America Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Service Type, 2021-2034
  • Table 8: North America Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 9: North America Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Application, 2021-2034
  • Table 10: North America Stem Cell Banking Market Revenue (USD BIllion) Forecast, By Country, 2021-2034
  • Table 11: U.S. Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 12: Canada Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 13: Europe Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Cell Type, 2021-2034
  • Table 14: Europe Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Service Type, 2021-2034
  • Table 15: Europe Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 16: Europe Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Application, 2021-2034
  • Table 17: Europe Stem Cell Banking Market Revenue (USD BIllion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 18: Germany Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 19: U.K. Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 20: France Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 21: Italy Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 22: Spain Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 23: Scandinavia Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 24: Rest of Europe Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 25: Asia Pacific Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Cell Type, 2021-2034
  • Table 26: Asia Pacific Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Service Type, 2021-2034
  • Table 27: Asia Pacific Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 28: Asia Pacific Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Application, 2021-2034
  • Table 29: Asia Pacific Stem Cell Banking Market Revenue (USD BIllion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 30: China Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 31: Japan Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 32: India Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 33: Australia Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 34: Southeast Asia Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 35: Rest of Asia Pacific Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 36: Latin America Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Cell Type, 2021-2034
  • Table 37: Latin America Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Service Type, 2021-2034
  • Table 38: Latin America Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 39: Latin America Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Application, 2021-2034
  • Table 40: Latin America Stem Cell Banking Market Revenue (USD BIllion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 41: Brazil Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 42: Mexico Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 43: Rest of Latin America Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 44: Middle East & Africa Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Cell Type, 2021-2034
  • Table 45: Middle East & Africa Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Service Type, 2021-2034
  • Table 46: Middle East & Africa Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 47: Middle East & Africa Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Application, 2021-2034
  • Table 48: Middle East & Africa Stem Cell Banking Market Revenue (USD BIllion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 49: GCC Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 50: South Africa Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 51: Rest of the Middle East & Africa Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034

List of Figures

  • Figure 1: Global Stem Cell Banking Market Revenue Breakdown (USD BIllion, %) by Region, 2026 & 2034
  • Figure 2: Global Stem Cell Banking Market Value Share (%), by Cell Type, 2026 & 2034
  • Figure 3: Global Stem Cell Banking Market Value Share (%), by Service Type, 2026 & 2034
  • Figure 4: Global Stem Cell Banking Market Value Share (%), by Bank Type, 2026 & 2034
  • Figure 5: Global Stem Cell Banking Market Value Share (%), by Application, 2026 & 2034
  • Figure 6: Global Stem Cell Banking Market Value Share (%), by Region, 2026 & 2034
  • Figure 7: North America Stem Cell Banking Market Value (USD BIllion), by Cell Type, 2026 & 2034
  • Figure 8: North America Stem Cell Banking Market Value Share (%), by Cell Type, 2026
  • Figure 9: North America Stem Cell Banking Market Value (USD BIllion), by Service Type, 2026 & 2034
  • Figure 10: North America Stem Cell Banking Market Value Share (%), by Service Type, 2026
  • Figure 11: North America Stem Cell Banking Market Value (USD BIllion), by Bank Type, 2026 & 2034
  • Figure 12: North America Stem Cell Banking Market Value Share (%), by Bank Type, 2026
  • Figure 13: North America Stem Cell Banking Market Value (USD BIllion), by Application, 2026 & 2034
  • Figure 14: North America Stem Cell Banking Market Value Share (%), by Application, 2026
  • Figure 15: North America Stem Cell Banking Market Value (USD BIllion), By Country, 2026 & 2034
  • Figure 16: North America Stem Cell Banking Market Value Share (%), By Country, 2026
  • Figure 17: Europe Stem Cell Banking Market Value (USD BIllion), by Cell Type, 2026 & 2034
  • Figure 18: Europe Stem Cell Banking Market Value Share (%), by Cell Type, 2026
  • Figure 19: Europe Stem Cell Banking Market Value (USD BIllion), by Service Type, 2026 & 2034
  • Figure 20: Europe Stem Cell Banking Market Value Share (%), by Service Type, 2026
  • Figure 21: Europe Stem Cell Banking Market Value (USD BIllion), by Bank Type, 2026 & 2034
  • Figure 22: Europe Stem Cell Banking Market Value Share (%), by Bank Type, 2026
  • Figure 23: Europe Stem Cell Banking Market Value (USD BIllion), by Application, 2026 & 2034
  • Figure 24: Europe Stem Cell Banking Market Value Share (%), by Application, 2026
  • Figure 25: Europe Stem Cell Banking Market Value (USD BIllion), By Country/ Sub-region, 2026 & 2034
  • Figure 26: Europe Stem Cell Banking Market Value Share (%), By Country/ Sub-region, 2026
  • Figure 27: Asia Pacific Stem Cell Banking Market Value (USD BIllion), by Cell Type, 2026 & 2034
  • Figure 28: Asia Pacific Stem Cell Banking Market Value Share (%), by Cell Type, 2026
  • Figure 29: Asia Pacific Stem Cell Banking Market Value (USD BIllion), by Service Type, 2026 & 2034
  • Figure 30: Asia Pacific Stem Cell Banking Market Value Share (%), by Service Type, 2026
  • Figure 31: Asia Pacific Stem Cell Banking Market Value (USD BIllion), by Bank Type, 2026 & 2034
  • Figure 32: Asia Pacific Stem Cell Banking Market Value Share (%), by Bank Type, 2026
  • Figure 33: Asia Pacific Stem Cell Banking Market Value (USD BIllion), by Application, 2026 & 2034
  • Figure 34: Asia Pacific Stem Cell Banking Market Value Share (%), by Application, 2026
  • Figure 35: Asia Pacific Stem Cell Banking Market Value (USD BIllion), By Country/ Sub-region, 2026 & 2034
  • Figure 36: Asia Pacific Stem Cell Banking Market Value Share (%), By Country/ Sub-region, 2026
  • Figure 37: Latin America Stem Cell Banking Market Value (USD BIllion), by Cell Type, 2026 & 2034
  • Figure 38: Latin America Stem Cell Banking Market Value Share (%), by Cell Type, 2026
  • Figure 39: Latin America Stem Cell Banking Market Value (USD BIllion), by Service Type, 2026 & 2034
  • Figure 40: Latin America Stem Cell Banking Market Value Share (%), by Service Type, 2026
  • Figure 41: Latin America Stem Cell Banking Market Value (USD BIllion), by Bank Type, 2026 & 2034
  • Figure 42: Latin America Stem Cell Banking Market Value Share (%), by Bank Type, 2026
  • Figure 43: Latin America Stem Cell Banking Market Value (USD BIllion), by Application, 2026 & 2034
  • Figure 44: Latin America Stem Cell Banking Market Value Share (%), by Application, 2026
  • Figure 45: Latin America Stem Cell Banking Market Value (USD BIllion), By Country/ Sub-region, 2026 & 2034
  • Figure 46: Latin America Stem Cell Banking Market Value Share (%), By Country/ Sub-region, 2026
  • Figure 47: Middle East & Africa Stem Cell Banking Market Value (USD BIllion), by Cell Type, 2026 & 2034
  • Figure 48: Middle East & Africa Stem Cell Banking Market Value Share (%), by Cell Type, 2026
  • Figure 49: Middle East & Africa Stem Cell Banking Market Value (USD BIllion), by Service Type, 2026 & 2034
  • Figure 50: Middle East & Africa Stem Cell Banking Market Value Share (%), by Service Type, 2026
  • Figure 51: Middle East & Africa Stem Cell Banking Market Value (USD BIllion), by Bank Type, 2026 & 2034
  • Figure 52: Middle East & Africa Stem Cell Banking Market Value Share (%), by Bank Type, 2026
  • Figure 53: Middle East & Africa Stem Cell Banking Market Value (USD BIllion), by Application, 2026 & 2034
  • Figure 54: Middle East & Africa Stem Cell Banking Market Value Share (%), by Application, 2026
  • Figure 55: Middle East & Africa Stem Cell Banking Market Value (USD BIllion), By Country/ Sub-region, 2026 & 2034
  • Figure 56: Middle East & Africa Stem Cell Banking Market Value Share (%), By Country/ Sub-region, 2026
  • Figure 57: Global Stem Cell Banking Market Share (%), By Company, 2026